Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nørgård Petersen, L."'
Autor:
Blons, H., Emile, J.F., Le Malicot, K., Julié, C., Zaanan, A., Tabernero, J., Mini, E., Folprecht, G., Van Laethem, J.L., Thaler, J., Bridgewater, J., Nørgård-Petersen, L., Van Cutsem, E., Lepage, C., Zawadi, M.A., Salazar, R., Laurent-Puig, P., Taieb, J. *
Publikováno v:
In Annals of Oncology December 2014 25(12):2378-2385
Autor:
Hansen, L.T., Thykjaer, T., Ørntoft, T.F., Rasmussen, L.J., Keller, P., Spang-Thomsen, M., Bocker Edmonston, T., Schmutte, C., Fishel, R., Nørgård Petersen, L.
Publikováno v:
In European Journal of Cancer July 2003 39(10):1456-1467
Autor:
H. Blons, J. F. Emile, K. Le Malicot, C. Julié, A. Zaanan, J. Tabernero, E. Mini, G. Folprecht, J. L. Van Laethem, J. Thaler, J. Bridgewater, L. Nørgård Petersen, E. Van Cutsem, C. Lepage, M. A. Zawadi, R. Salazar, P. Laurent Puig, J. Taieb, PETACC8 investigators: […, Andrea Martoni, BIASCO, GUIDO
Publikováno v:
Annals of Oncology. 25:2378-2385
BACKGROUND: The prognostic value of KRAS mutations in colon adenocarcinoma is controversial. We examined this question as an ancillary study of the PETACC8 phase III trial.PATIENTS AND METHODS: We analyzed the prognostic impact of KRAS exon 2 mutatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27095b7aab4a25681eb8dc88bc483247
https://doi.org/10.1093/annonc/mdu464
https://doi.org/10.1093/annonc/mdu464